Skip to main navigation Skip to search Skip to main content

Efficacy of parainfluenza virus 5 (PIV5)-vectored intranasal COVID-19 vaccine as a single dose primer and booster against SARS-CoV-2 variants

  • Ashley C. Beavis
  • , Zhuo Li
  • , Kelsey Briggs
  • , María Cristina Gingerich
  • , Elizabeth R. Wrobel
  • , Maria Najera
  • , Dong An
  • , Nichole Orr-Burks
  • , Jackelyn Murray
  • , Preetish Patil
  • , Jiachen Huang
  • , Jarrod Mousa
  • , Linhui Hao
  • , Tien Ying Hsiang
  • , Michael G. Gale
  • , Stephen B. Harvey
  • , S. Mark Tompkins
  • , Robert Jeffrey Hogan
  • , Eric R. Lafontaine
  • , Hong Jin
  • Biao He

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Efficacy of parainfluenza virus 5 (PIV5)-vectored intranasal COVID-19 vaccine as a single dose primer and booster against SARS-CoV-2 variants'. Together they form a unique fingerprint.
Sort by

Immunology and Microbiology

Keyphrases